|
1
|
Kirchhoff C, Habben I, Ivell R and Krull
N: A major human epididymis-specific cDNA encodes a protein with
sequence homology to extracellular proteinase inhibitors. Biol
Reprod. 45:350–357. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma Q, Wang Q and Zhong D: Advances of
human epididymis protein 4 in lung cancer. Zhongguo Fei Ai Za Zhi.
18:184–186. 2015.(In Chinese). PubMed/NCBI
|
|
3
|
Hua L, Liu Y, Zhen S, Wan D, Cao J and Gao
X: Expression and biochemical characterization of recombinant human
epididymis protein 4. Protein Expr Purif. 102:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lu R, Sun X, Xiao R, Zhou L, Gao X and Guo
L: Human epididymis protein 4 (HE4) plays a key role in ovarian
cancer cell adhesion and motility. Biochem Biophys Res Commun.
419:274–280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bingle L, Cross SS, High AS, Wallace WA,
Rassl D, Yuan G, Hellstrom I, Campos MA and Bingle CD: WFDC2 (HE4):
A potential role in the innate immunity of the oral cavity and
respiratory tract and the development of adenocarcinomas of the
lung. Respir Res. 7:612006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zeng Q, Liu M, Zhou N, Liu L and Song X:
Serum human epididymis protein 4 (HE4) may be a better tumor marker
in early lung cancer. Clin Chim Acta. 455:102–106. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Fan Y, Wang J, Wang H and Liu W:
Evaluating the expression and diagnostic value of human epididymis
protein 4 (HE4) in small cell lung cancer. Tumour Biol.
35:6847–6853. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu W, Yang J, Chi PD, Zheng X, Dai SQ,
Chen H, Xu BL and Liu WL: Evaluating the clinical significance of
serum HE4 levels in lung cancer and pulmonary tuberculosis. Int J
Tuberc Lung Dis. 17:1346–1353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamashita S, Tokuishi K, Moroga T,
Yamamoto S, Ohbo K, Miyahara S, Yoshida Y, Yanagisawa J, Hamatake
D, Hiratsuka M, et al: Serum level of HE4 is closely associated
with pulmonary adenocarcinoma progression. Tumour Biol.
33:2365–2370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wojcik E, Tarapacz J, Rychlik U, Stasik Z,
Sas-Korczynska B, Skotnicki P and Kulpa JK: Human epididymis
protein 4 (HE4) in patients with small-cell lung cancer. Clin Lab.
62:1625–1632. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lan WG, Hao YZ, Xu DH, Wang P, Zhou YL and
Ma LB: Serum human epididymis protein 4 is associated with the
treatment response of concurrent chemoradiotherapy and prognosis in
patients with locally advanced non-small cell lung cancer. Clin
Transl Oncol. 18:375–380. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamashita S, Tokuishi K, Hashimoto T,
Moroga T, Kamei M, Ono K, Miyawaki M, Takeno S, Chujo M, Yamamoto
S, et al: Prognostic significance of HE4 expression in pulmonary
adenocarcinoma. Tumour Biol. 32:265–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bulut T, Celik B, Yalcin AD and Keser S:
Tissue expression of HE4 a and its correlation with CA125 and P53
in high grade serous ovarian carcinoma. Eur J Gynaecol Oncol. doi:
10.12892/ejgo3992.2017 (Epub ahead of print). PubMed/NCBI
|
|
14
|
Yang Z, Zhang Z, Qin B, et al: Human
epididymis protein 4: A novel biomarker for lupus nephritis and
chronic kidney disease in systemic lupus erythematosus. J Clin Lab
Anal. 897–904. 2016.doi: 10.1002/jcla.21954. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yoon HI, Kwon OR, Kang KN, Shin YS, Shin
HS, Yeon EH, Kwon KY, Hwang I, Jeon YK, Kim Y, et al: Diagnostic
value of combining tumor and inflammatory markers in lung cancer. J
Cancer Prev. 21:187–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nagy B Jr, Bhattoa HP, Steiber Z, Csobán
M, Szilasi M, Méhes G, Müller M, Lázár J, Kappelmayer J and
Antal-Szalmás P: Serum human epididymis protein 4 (HE4) as a tumor
marker in men with lung cancer. Clin Chem Lab Med. 52:1639–1648.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iwahori K, Suzuki H, Kishi Y, Fujii Y,
Uehara R, Okamoto N, Kobayashi M, Hirashima T, Kawase I and Naka T:
Serum HE4 as a diagnostic and prognostic marker for lung cancer.
Tumour Biol. 33:1141–1149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang QF, Zhou ZW, Ji HB, Pan WH and Sun
MZ: Value of serum marker HE4 in pulmonary carcinoma diagnosis. Int
J Clin Exp Med. 8:19014–19021. 2015.PubMed/NCBI
|
|
19
|
Huang W, Wu S, Lin Z, Chen P and Wu G:
Evaluation of HE4 in the diagnosis and follow up of non-small cell
lung cancers. Clin Lab. 63:461–467. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lou E, Johnson M, Sima C,
Gonzalez-Espinoza R, Fleisher M, Kris MG and Azzoli CG: Serum
biomarkers for assessing histology and outcomes in patients with
metastatic lung cancer. Cancer Biomark. 14:207–214. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Drapkin R, von Horsten HH, Lin Y, Mok SC,
Crum CP, Welch WR and Hecht JL: Human epididymis protein 4 (HE4) is
a secreted glycoprotein that is overexpressed by serous and
endometrioid ovarian carcinomas. Cancer Res. 65:2162–2169. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mangum MD, Greco FA, Hainsworth JD, Hande
KR and Johnson DH: Combined small-cell and non-small-cell lung
cancer. J Clin Oncol. 7:607–612. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wallace AS, Arya M, Frazier SR, Westgate
S, Wang Z and Doll D: Combined small-cell lung carcinoma: An
institutional experience. Thorac Cancer. 5:57–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
